Orion Infusion Limited (DSE:ORIONINFU)

Orion Infusion Statistics

Total Valuation

Orion Infusion has a market cap or net worth of BDT 7.27 billion. The enterprise value is 7.56 billion.

Market Cap	7.27B
Enterprise Value	7.56B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Dec 2, 2025

Share Statistics

Orion Infusion has 20.36 million shares outstanding.

Current Share Class	20.36M
Shares Outstanding	20.36M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 204.05.

PE Ratio	204.05
Forward PE	n/a
PS Ratio	11.51
PB Ratio	21.53
P/TBV Ratio	21.53
P/FCF Ratio	247.19
P/OCF Ratio	222.79
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 77.36, with an EV/FCF ratio of 257.16.

EV / Earnings	212.27
EV / Sales	11.98
EV / EBITDA	77.36
EV / EBIT	93.45
EV / FCF	257.16

Financial Position

The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.92.

Current Ratio	0.97
Quick Ratio	0.37
Debt / Equity	0.92
Debt / EBITDA	3.17
Debt / FCF	10.55
Interest Coverage	2.18

Financial Efficiency

Return on equity (ROE) is 10.74% and return on invested capital (ROIC) is 7.84%.

Return on Equity (ROE)	10.74%
Return on Assets (ROA)	6.05%
Return on Invested Capital (ROIC)	7.84%
Return on Capital Employed (ROCE)	22.06%
Revenue Per Employee	1.12M
Profits Per Employee	63,289
Employee Count	563
Asset Turnover	0.76
Inventory Turnover	3.31

Taxes

In the past 12 months, Orion Infusion has paid 9.16 million in taxes.

Income Tax	9.16M
Effective Tax Rate	20.45%

Stock Price Statistics

The stock price has decreased by -17.26% in the last 52 weeks. The beta is -2.52, so Orion Infusion's price volatility has been lower than the market average.

Beta (5Y)	-2.52
52-Week Price Change	-17.26%
50-Day Moving Average	394.56
200-Day Moving Average	404.08
Relative Strength Index (RSI)	36.47
Average Volume (20 Days)	284,575

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Infusion had revenue of BDT 631.54 million and earned 35.63 million in profits. Earnings per share was 1.75.

Revenue	631.54M
Gross Profit	265.77M
Operating Income	80.94M
Pretax Income	44.79M
Net Income	35.63M
EBITDA	90.96M
EBIT	80.94M
Earnings Per Share (EPS)	1.75

Balance Sheet

The company has 10.20 million in cash and 310.32 million in debt, giving a net cash position of -293.12 million or -14.40 per share.

Cash & Cash Equivalents	10.20M
Total Debt	310.32M
Net Cash	-293.12M
Net Cash Per Share	-14.40
Equity (Book Value)	337.72M
Book Value Per Share	16.59
Working Capital	-13.60M

Cash Flow

In the last 12 months, operating cash flow was 32.63 million and capital expenditures -3.22 million, giving a free cash flow of 29.41 million.

Operating Cash Flow	32.63M
Capital Expenditures	-3.22M
Free Cash Flow	29.41M
FCF Per Share	1.44

Margins

Gross margin is 42.08%, with operating and profit margins of 12.82% and 5.64%.

Gross Margin	42.08%
Operating Margin	12.82%
Pretax Margin	7.09%
Profit Margin	5.64%
EBITDA Margin	14.40%
EBIT Margin	12.82%
FCF Margin	4.66%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.56%.

Dividend Per Share	2.00
Dividend Yield	0.56%
Dividend Growth (YoY)	66.67%
Years of Dividend Growth	1
Payout Ratio	65.84%
Buyback Yield	n/a
Shareholder Yield	0.59%
Earnings Yield	0.49%
FCF Yield	0.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.

Last Split Date	Dec 4, 2011
Split Type	Forward
Split Ratio	10

Scores

Orion Infusion has an Altman Z-Score of 10.08 and a Piotroski F-Score of 5.

Altman Z-Score	10.08
Piotroski F-Score	5